2026-10-23 · By SEPT AI
*By SEPT AI*
U.S. equities finished Friday's session with little direction at the index level, though beneath the calm surface a busy tape delivered sharp moves in individual names. The S&P 500 proxy SPY closed essentially flat at $759.97, up 0.01%, after trading in a range between $758.68 and $763.47. The Nasdaq-100 proxy QQQ added 0.31% to close at $704.40, while the small-cap Russell 2000 proxy IWM gained 0.32% to $275.72. The Dow proxy DIA was the laggard, slipping 0.26% to $521.37. The Fear & Greed Index sat at 50, squarely in neutral territory, reflecting a market with no clear directional conviction.
The split between the Dow and the Nasdaq/small-cap complex told the day's story. Large-cap industrial and financial names weighed on the blue-chip average, while technology and smaller companies found modest bids. The narrow trading ranges on SPY and QQQ — barely a fraction of a percent from open to close — suggested investors were content to hold positions into the weekend rather than make bold directional bets. The neutral sentiment reading reinforced that posture.
The most dramatic move of the session came from AIOK, which surged 116.58% to close at $12.02 on volume of more than 40 million shares — by far the heaviest turnover among the day's extreme movers. CLRO followed with a 64.97% jump to $3.25 on 28.3 million shares. JYD rose 31.29% to $1.82, HTCO climbed 26.45% to $1.53, and NAUT gained 25.76% to $3.24 on 13.1 million shares. UWMC advanced 23.93% to $1.45 on 24.7 million shares, while CNDT added 21.77% to $1.79 and QSI rose 21.21% to $1.40.
On the downside, AARD collapsed 53.51% to $1.39, the worst decline of the day. NCPL fell 36.43% to $1.33, MGNX dropped 36.22% to $2.25, and CATX lost 32.92% to $1.61. FGL declined 30.38% to $1.81, XLAB shed 23.34% to $3.35, and POM fell 23.28% to $1.17. CANG slipped 22.65% to $1.81, while YMAT dropped 19.29% to $2.05 on heavy volume of 29.1 million shares, and TCRT lost 19.08% to $2.29.
Deal News and Corporate Catalysts
Merger activity dominated the headlines. SpaceX confirmed that a potential merger with Tesla would require approval from its controlling shareholder, a disclosure that keeps one of the most closely watched corporate combinations in play. Gooch & Housego's buyout is being backed by $300 million in borrowed funds, with Blackstone leading the loan package. BASF raised its takeover offer for Evonik, sweetening its previous proposal. Safran is in acquisition talks with Exail Technologies, and Logan Energy Corp. is exploring a possible sale. Bolt Biotherapeutics also disclosed a major company event tied to a merger.
In biotech, Intensity Therapeutics reported encouraging initial results for INT230-6 in its INVINCIBLE-4 trial. Wave Life Sciences said early-stage data for WVE-007 was positive and that regulators are aligned on WVE-006. Moderna and Merck released late-stage cancer vaccine trial data. Zymeworks granted Roche worldwide rights to ZW209 under a new partnership.
On the industrial and agricultural side, Intrepid Potash was selected for a USDA fertilizer investment and expansion program, and Logistic Properties of the Americas began an $85 million logistics project in Peru.
Several companies disclosed filings that pointed to potential dilution or compliance matters, including Ensysce Biosciences, Aterian, Bio Green Med Solution, and Edgemode, each of which filed shelf registrations or major-event reports.
A broad slate of companies reported. American Express beat expectations with earnings of $4.68 per share against a $4.50 estimate, though revenue of $20.06 billion came in just shy of the $20.12 billion consensus. First Citizens BancShares posted a blowout quarter, earning $55.37 per share versus a $46.18 estimate, with revenue of $2.43 billion topping the $2.26 billion forecast. Booz Allen Hamilton beat on both lines, earning $1.76 per share against a $1.48 estimate on revenue of $2.78 billion. Eni reported $2.13 per share versus a $1.87 estimate, with revenue of $28.72 billion far exceeding the $25.89 billion consensus. Balchem earned $1.57 per share against a $1.43 estimate. Holcim reported strong third-quarter 2026 results and raised its full-year outlook.
Among the misses, Autoliv earned $2.19 per share versus a $2.23 estimate on slightly light revenue, and First Hawaiian came in at $0.52 per share against a $0.589 estimate. Flagstar Financial earned just $0.01 per share against a $0.0723 estimate, with revenue also falling short. Euronext posted $1.45 per share versus a $1.53 estimate. GrafTech's loss of $1.21 per share was narrower than the expected $1.38 loss, and revenue beat.
Filings over recent months show continued insider accumulation in several names. Republic Services stands out with 95 buy transactions totaling roughly $1.24 billion. Taiwan Semiconductor has seen 78 buys worth about $858,171. Other names showing consistent insider buying include Ecolab with four buys worth $2.7 million, MercadoLibre with three buys totaling $1.2 million, Loews with two buys worth $1.1 million, and Huntington Bancshares with seven buys totaling $617,560. FBK, GBCI, IP, and NHI also registered insider purchases.
With the Fear & Greed Index at neutral and major averages pinned in tight ranges, investors head into the weekend without a strong signal. The coming week brings a fresh wave of earnings and the potential for more deal headlines, particularly around the SpaceX-Tesla and BASF-Evonik situations. Small caps outperformed Friday, and whether that rotation persists will be a key tell for market breadth. For now, the tape remains a stock picker's market — quiet at the index level, but anything but quiet underneath.
Access real-time market data, AI analysis, dark pool activity, and options flow.
Start Free Trial